GM6001 Increases Anastomotic Leakage following Colonic Obstruction Possibly by Impeding Epithelialization.

Martin Rehn, Peter-Martin Krarup, Lise H Christensen, Jakob B Seidelin, Magnus S Ågren, Ingvar Syk
Author Information
  1. Martin Rehn: 1 Department of Surgery, Skåne University Hospital , Malmö, Sweden .
  2. Peter-Martin Krarup: 2 Digestive Disease Center, Bispebjerg Hospital, University of Copenhagen , Copenhagen, Denmark .
  3. Lise H Christensen: 3 Department of Pathology, Bispebjerg Hospital, University of Copenhagen , Copenhagen, Denmark .
  4. Jakob B Seidelin: 2 Digestive Disease Center, Bispebjerg Hospital, University of Copenhagen , Copenhagen, Denmark .
  5. Magnus S Ågren: 2 Digestive Disease Center, Bispebjerg Hospital, University of Copenhagen , Copenhagen, Denmark .
  6. Ingvar Syk: 1 Department of Surgery, Skåne University Hospital , Malmö, Sweden .

Abstract

BACKGROUND: Emergency operations performed on an obstructed colon are accompanied by an increased risk of anastomotic insufficiency. Tissue-destructive matrix metalloproteinase (MMP) activity is elevated in the obstructed colon and contributes to a loss of suture-holding submucosal collagen, which may be mediated by tumor necrosis factor (TNF)-α. Our aim was to study the effect of the non-selective MMP and TNF-α converting enzyme (TACE) inhibitor GM6001 (30 mg/kg) on anastomosis repair in obstructed left colon. GM6001 has been proved to be highly efficacious in elective anastomosis rodent models.
METHODS: A partial obstruction of the distal colon was induced in male Sprague-Dawley rats. After 4 d the obstructed colonic segment was resected, and an end-to-end anastomosis was constructed. Seven days later, the anastomoses were evaluated for clinical leakage. Histopathological and immunohistochemical assessments were also performed. Finally, the direct effect of GM6001 on epithelialization was studied in cultured colonic epithelial cells.
RESULTS: Unlike the robust beneficial effect on anastomosis under uncomplicated conditions, here GM6001 had a negative impact on anastomotic wound healing following colonic obstruction and substantially (p=0.004) more rats in the GM6001 group (75%) than in the control group (11%) had developed anastomotic leakage. In the anastomotic wounds, the myofibroblast abundance and cell proliferation were similar in the two groups. Histologically, GM6001 treatment resulted in wider and minimally epithelialized wounds that were commonly necrotic on the luminal side and infiltrated with numerous granulocytes. In vitro, GM6001 also delayed (p=0.026) epithelialization of denuded intestinal epithelium grown on type I collagen.
CONCLUSIONS: Non-selective MMP/TACE inhibition with GM6001 increased the anastomotic complications following colon obstruction. Inhibition of epithelialization is one possible mechanism responsible for the increased leakage following GM6001 treatment.

References

  1. Int J Colorectal Dis. 2008 Mar;23(3):271-6 [PMID: 18043927]
  2. Surgery. 2006 Jul;140(1):72-82 [PMID: 16857445]
  3. Bioorg Med Chem. 2008 Oct 1;16(19):8781-94 [PMID: 18790648]
  4. Nature. 2009 Jul 30;460(7255):637-41 [PMID: 19536155]
  5. Surgery. 2010 Mar;147(3):339-51 [PMID: 20004450]
  6. J Surg Res. 2010 Nov;164(1):e73-6 [PMID: 20828736]
  7. Int J Colorectal Dis. 2011 Mar;26(3):329-37 [PMID: 21193914]
  8. BMC Surg. 2011;11:6 [PMID: 21366898]
  9. J Enzyme Inhib Med Chem. 2011 Apr;26(2):181-7 [PMID: 21406033]
  10. Colorectal Dis. 2011 Jul;13(7):e165-9 [PMID: 21651691]
  11. Aliment Pharmacol Ther. 2012 Jun;35(11):1301-9 [PMID: 22506582]
  12. Aliment Pharmacol Ther. 2012 Nov;36(10):922-8 [PMID: 23002804]
  13. Inflamm Bowel Dis. 2012 Dec;18(12):2404-13 [PMID: 22467533]
  14. Int J Colorectal Dis. 2013 Mar;28(3):341-7 [PMID: 22903297]
  15. Int J Colorectal Dis. 2013 Aug;28(8):1151-9 [PMID: 23619615]
  16. Br J Surg. 2014 Apr;101(5):539-45 [PMID: 24615529]
  17. Dis Colon Rectum. 2013 Dec;56(12):1423-33 [PMID: 24201398]
  18. J Crohns Colitis. 2013 Dec;7(11):868-77 [PMID: 23466411]
  19. Curr Eye Res. 2014 May;39(5):460-71 [PMID: 24400880]
  20. J Surg Res. 2014 Jun 1;189(1):22-31 [PMID: 24582070]
  21. BMC Surg. 2014;14:23 [PMID: 24762063]
  22. Int J Surg. 2014;12(9):969-75 [PMID: 25091401]
  23. Dis Colon Rectum. 1990 Mar;33(3):217-21 [PMID: 2311466]
  24. World J Gastroenterol. 2014 Sep 21;20(35):12637-48 [PMID: 25253969]
  25. Br J Surg. 2001 Jan;88(1):90-8 [PMID: 11136318]
  26. Br J Surg. 2001 Feb;88(2):228-34 [PMID: 11167872]
  27. Dis Colon Rectum. 2003 Sep;46(9):1251-9 [PMID: 12972971]
  28. Virchows Arch. 2003 Dec;443(6):774-81 [PMID: 14564519]
  29. J Periodontal Res. 2004 Aug;39(4):269-74 [PMID: 15206921]
  30. Exp Cell Res. 2004 Oct 1;299(2):465-75 [PMID: 15350544]
  31. Nature. 1985 Aug 8-14;316(6028):552-4 [PMID: 2993897]
  32. Ann Surg. 1987 Aug;206(2):138-41 [PMID: 3496862]
  33. Acta Chir Scand. 1988 May-Jun;154(5-6):389-93 [PMID: 3421007]
  34. Nature. 1997 Feb 20;385(6618):729-33 [PMID: 9034190]
  35. J Am Coll Surg. 1997 Apr;184(4):364-72 [PMID: 9100681]
  36. Br J Surg. 1998 Jan;85(1):72-5 [PMID: 9462388]
  37. J Med Chem. 1998 Apr 9;41(8):1209-17 [PMID: 9548812]
  38. Am J Surg. 1998 Jul;176(1):18-24 [PMID: 9683126]
  39. Surgery. 1998 Aug;124(2):464-70 [PMID: 9706172]
  40. J Biol Chem. 1999 Jan 22;274(4):2446-55 [PMID: 9891015]
  41. Surgery. 2005 Feb;137(2):229-34 [PMID: 15674206]
  42. Eur Surg Res. 2005 Jan-Feb;37(1):68-75 [PMID: 15818044]
  43. Oral Dis. 2005 Nov;11(6):408-9 [PMID: 16269035]
  44. Int J Biochem Cell Biol. 2008;40(6-7):1334-47 [PMID: 18083622]

MeSH Term

Anastomotic Leak
Animals
Caco-2 Cells
Colon
Dipeptides
Disease Models, Animal
Epithelial Cells
Histocytochemistry
Humans
Immunohistochemistry
Intestinal Obstruction
Male
Matrix Metalloproteinase Inhibitors
Rats, Sprague-Dawley

Chemicals

Dipeptides
Matrix Metalloproteinase Inhibitors
N-(2(R)-2-(hydroxamidocarbonylmethyl)-4-methylpentanoyl)-L-tryptophan methylamide

Word Cloud

Created with Highcharts 10.0.0GM6001colonanastomoticobstructedanastomosisfollowingincreasedeffectobstructioncolonicleakageepithelializationperformedMMPcollagenratsalsop=0groupwoundstreatmentBACKGROUND:EmergencyoperationsaccompaniedriskinsufficiencyTissue-destructivematrixmetalloproteinaseactivityelevatedcontributeslosssuture-holdingsubmucosalmaymediatedtumornecrosisfactorTNFaimstudynon-selectiveTNF-αconvertingenzymeTACEinhibitor30 mg/kgrepairleftprovedhighlyefficaciouselectiverodentmodelsMETHODS:partialdistalinducedmaleSprague-Dawley4dsegmentresectedend-to-endconstructedSevendayslateranastomosesevaluatedclinicalHistopathologicalimmunohistochemicalassessmentsFinallydirectstudiedculturedepithelialcellsRESULTS:Unlikerobustbeneficialuncomplicatedconditionsnegativeimpactwoundhealingsubstantially00475%control11%developedmyofibroblastabundancecellproliferationsimilartwogroupsHistologicallyresultedwiderminimallyepithelializedcommonlynecroticluminalsideinfiltratednumerousgranulocytesvitrodelayed026denudedintestinalepitheliumgrowntypeCONCLUSIONS:Non-selectiveMMP/TACEinhibitioncomplicationsInhibitiononepossiblemechanismresponsibleIncreasesAnastomoticLeakageColonicObstructionPossiblyImpedingEpithelialization

Similar Articles

Cited By